 | • レポートコード：MRC22NVL17100 • 出版社/出版日：LP Information / 2022年10月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界経済が回復するにつれて、2021年の心臓胸部低侵襲手術用器具の成長は前年から大幅に変化します。LP Information社（米国）の最新の調査によると、世界の心臓胸部低侵襲手術用器具市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年～2022年間に000%の成長が予想されます。2028年には世界の心臓胸部低侵襲手術用器具市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。 米国の心臓胸部低侵襲手術用器具市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界の心臓胸部低侵襲手術用器具市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州の心臓胸部低侵襲手術用器具の状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。 世界の主要な心臓胸部低侵襲手術用器具プレーヤーとして、Medtronic、 Aesculap、 Stryker Corporation、 Smith & Nephew、 Ethicon、 Conmed Corporation、 Zimmer Holdings、 MI、 KARL STORZ、 Genesee BioMedicalなどをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。 当レポートでは、製品タイプ、用途（アプリケーション）、主要メーカー、主要地域および国ごとの心臓胸部低侵襲手術用器具市場の包括的な概要、市場シェア、および成長機会を掲載します。 タイプ別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 手持ち器具、ガイド装置、インフレーションシステム、補助器具、カッター器具 用途（アプリケーション）別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 心臓弁手術、心臓動脈バイパス、心臓切除、心室中隔欠損症、心房中隔欠損症、その他 当レポートは次の地域と国の市場規模データを掲載します。 南北アメリカ（米国、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東/アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：心臓胸部低侵襲手術用器具の年間販売量2017-2028、地域別現状・将来分析 ・心臓胸部低侵襲手術用器具のタイプ別セグメント：手持ち器具、ガイド装置、インフレーションシステム、補助器具、カッター器具 ・心臓胸部低侵襲手術用器具のタイプ別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 ・心臓胸部低侵襲手術用器具の用途別セグメント：心臓弁手術、心臓動脈バイパス、心臓切除、心室中隔欠損症、心房中隔欠損症、その他 ・心臓胸部低侵襲手術用器具の用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 企業別世界の心臓胸部低侵襲手術用器具市場 ・企業別のグローバル心臓胸部低侵襲手術用器具市場データ：2020-2022年の年間販売量、市場シェア ・企業別の心臓胸部低侵襲手術用器具の年間売上：2020-2022年の売上、市場シェア ・企業別の心臓胸部低侵襲手術用器具販売価格 ・主要企業の心臓胸部低侵襲手術用器具生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 心臓胸部低侵襲手術用器具の地域別レビュー ・地域別の心臓胸部低侵襲手術用器具市場規模2017-2022：年間販売量、売上 ・主要国別の心臓胸部低侵襲手術用器具市場規模2017-2022：年間販売量、売上 ・南北アメリカの心臓胸部低侵襲手術用器具販売の成長 ・アジア太平洋の心臓胸部低侵襲手術用器具販売の成長 ・欧州の心臓胸部低侵襲手術用器具販売の成長 ・中東・アフリカの心臓胸部低侵襲手術用器具販売の成長 南北アメリカ市場 ・南北アメリカの国別の心臓胸部低侵襲手術用器具販売量、売上（2017-2022） ・南北アメリカの心臓胸部低侵襲手術用器具の種類別販売量 ・南北アメリカの心臓胸部低侵襲手術用器具の用途別販売量 ・米国の心臓胸部低侵襲手術用器具市場 ・カナダの心臓胸部低侵襲手術用器具市場 ・メキシコの心臓胸部低侵襲手術用器具市場 ・ブラジルの心臓胸部低侵襲手術用器具市場 アジア太平洋市場 ・アジア太平洋の国別の心臓胸部低侵襲手術用器具販売量、売上（2017-2022） ・アジア太平洋の心臓胸部低侵襲手術用器具の種類別販売量 ・アジア太平洋の心臓胸部低侵襲手術用器具の用途別販売量 ・中国市場の心臓胸部低侵襲手術用器具市場 ・日本市場の心臓胸部低侵襲手術用器具市場 ・韓国市場の心臓胸部低侵襲手術用器具市場 ・東南アジアの心臓胸部低侵襲手術用器具市場 ・インドの心臓胸部低侵襲手術用器具市場 ・オーストラリアの心臓胸部低侵襲手術用器具市場 ・台湾の心臓胸部低侵襲手術用器具市場 欧州市場 ・欧州の国別の心臓胸部低侵襲手術用器具販売量、売上（2017-2022） ・欧州の心臓胸部低侵襲手術用器具の種類別販売量 ・欧州の心臓胸部低侵襲手術用器具の用途別販売量 ・ドイツの心臓胸部低侵襲手術用器具市場 ・フランスの心臓胸部低侵襲手術用器具市場 ・イギリスの心臓胸部低侵襲手術用器具市場 ・イタリアの心臓胸部低侵襲手術用器具市場 ・ロシアの心臓胸部低侵襲手術用器具市場 中東・アフリカ市場 ・中東・アフリカの国別の心臓胸部低侵襲手術用器具販売量、売上（2017-2022） ・中東・アフリカの心臓胸部低侵襲手術用器具の種類別販売量 ・中東・アフリカの心臓胸部低侵襲手術用器具の用途別販売量 ・エジプトの心臓胸部低侵襲手術用器具市場 ・南アフリカの心臓胸部低侵襲手術用器具市場 ・イスラエルの心臓胸部低侵襲手術用器具市場 ・トルコの心臓胸部低侵襲手術用器具市場 ・GCC諸国の心臓胸部低侵襲手術用器具市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・心臓胸部低侵襲手術用器具の製造コスト構造分析 ・心臓胸部低侵襲手術用器具の製造プロセス分析 ・心臓胸部低侵襲手術用器具の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・心臓胸部低侵襲手術用器具の主要なグローバル販売業者 ・心臓胸部低侵襲手術用器具の主要なグローバル顧客 地域別の心臓胸部低侵襲手術用器具市場予測レビュー ・地域別の心臓胸部低侵襲手術用器具市場規模予測（2023-2028） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・心臓胸部低侵襲手術用器具のタイプ別市場規模予測 ・心臓胸部低侵襲手術用器具の用途別市場規模予測 主要企業分析 Medtronic、 Aesculap、 Stryker Corporation、 Smith & Nephew、 Ethicon、 Conmed Corporation、 Zimmer Holdings、 MI、 KARL STORZ、 Genesee BioMedical ・企業情報 ・心臓胸部低侵襲手術用器具製品 ・心臓胸部低侵襲手術用器具販売量、売上、価格、粗利益（2020-2022） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
As the global economy mends, the 2021 growth of Cardiothoracic Minimally Invasive Surgical Instruments will have significant change from previous year. According to our (LP Information) latest study, the global Cardiothoracic Minimally Invasive Surgical Instruments market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cardiothoracic Minimally Invasive Surgical Instruments market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Cardiothoracic Minimally Invasive Surgical Instruments market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cardiothoracic Minimally Invasive Surgical Instruments market, reaching US$ million by the year 2028. As for the Europe Cardiothoracic Minimally Invasive Surgical Instruments landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cardiothoracic Minimally Invasive Surgical Instruments players cover Medtronic, Aesculap, Stryker Corporation, and Smith & Nephew, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiothoracic Minimally Invasive Surgical Instruments market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Handheld Instruments
Guiding Device
Inflation Systems
Auxiliary Instruments
Cutter Instruments
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Heart Valve Surgery
Heart Artery Bypass
Cardiac Ablation
Ventricular Septal Defect
Atrial Septal Defect
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Medtronic
Aesculap
Stryker Corporation
Smith & Nephew
Ethicon
Conmed Corporation
Zimmer Holdings
MI
KARL STORZ
Genesee BioMedical
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cardiothoracic Minimally Invasive Surgical Instruments by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cardiothoracic Minimally Invasive Surgical Instruments by Country/Region, 2017, 2022 & 2028
2.2 Cardiothoracic Minimally Invasive Surgical Instruments Segment by Type
2.2.1 Handheld Instruments
2.2.2 Guiding Device
2.2.3 Inflation Systems
2.2.4 Auxiliary Instruments
2.2.5 Cutter Instruments
2.3 Cardiothoracic Minimally Invasive Surgical Instruments Sales by Type
2.3.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Sales Market Share by Type (2017-2022)
2.3.2 Global Cardiothoracic Minimally Invasive Surgical Instruments Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cardiothoracic Minimally Invasive Surgical Instruments Sale Price by Type (2017-2022)
2.4 Cardiothoracic Minimally Invasive Surgical Instruments Segment by Application
2.4.1 Heart Valve Surgery
2.4.2 Heart Artery Bypass
2.4.3 Cardiac Ablation
2.4.4 Ventricular Septal Defect
2.4.5 Atrial Septal Defect
2.4.6 Other
2.5 Cardiothoracic Minimally Invasive Surgical Instruments Sales by Application
2.5.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Sale Market Share by Application (2017-2022)
2.5.2 Global Cardiothoracic Minimally Invasive Surgical Instruments Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cardiothoracic Minimally Invasive Surgical Instruments Sale Price by Application (2017-2022)
3 Global Cardiothoracic Minimally Invasive Surgical Instruments by Company
3.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Breakdown Data by Company
3.1.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Annual Sales by Company (2020-2022)
3.1.2 Global Cardiothoracic Minimally Invasive Surgical Instruments Sales Market Share by Company (2020-2022)
3.2 Global Cardiothoracic Minimally Invasive Surgical Instruments Annual Revenue by Company (2020-2022)
3.2.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Revenue by Company (2020-2022)
3.2.2 Global Cardiothoracic Minimally Invasive Surgical Instruments Revenue Market Share by Company (2020-2022)
3.3 Global Cardiothoracic Minimally Invasive Surgical Instruments Sale Price by Company
3.4 Key Manufacturers Cardiothoracic Minimally Invasive Surgical Instruments Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiothoracic Minimally Invasive Surgical Instruments Product Location Distribution
3.4.2 Players Cardiothoracic Minimally Invasive Surgical Instruments Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cardiothoracic Minimally Invasive Surgical Instruments by Geographic Region
4.1 World Historic Cardiothoracic Minimally Invasive Surgical Instruments Market Size by Geographic Region (2017-2022)
4.1.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cardiothoracic Minimally Invasive Surgical Instruments Annual Revenue by Geographic Region
4.2 World Historic Cardiothoracic Minimally Invasive Surgical Instruments Market Size by Country/Region (2017-2022)
4.2.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cardiothoracic Minimally Invasive Surgical Instruments Annual Revenue by Country/Region
4.3 Americas Cardiothoracic Minimally Invasive Surgical Instruments Sales Growth
4.4 APAC Cardiothoracic Minimally Invasive Surgical Instruments Sales Growth
4.5 Europe Cardiothoracic Minimally Invasive Surgical Instruments Sales Growth
4.6 Middle East & Africa Cardiothoracic Minimally Invasive Surgical Instruments Sales Growth
5 Americas
5.1 Americas Cardiothoracic Minimally Invasive Surgical Instruments Sales by Country
5.1.1 Americas Cardiothoracic Minimally Invasive Surgical Instruments Sales by Country (2017-2022)
5.1.2 Americas Cardiothoracic Minimally Invasive Surgical Instruments Revenue by Country (2017-2022)
5.2 Americas Cardiothoracic Minimally Invasive Surgical Instruments Sales by Type
5.3 Americas Cardiothoracic Minimally Invasive Surgical Instruments Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiothoracic Minimally Invasive Surgical Instruments Sales by Region
6.1.1 APAC Cardiothoracic Minimally Invasive Surgical Instruments Sales by Region (2017-2022)
6.1.2 APAC Cardiothoracic Minimally Invasive Surgical Instruments Revenue by Region (2017-2022)
6.2 APAC Cardiothoracic Minimally Invasive Surgical Instruments Sales by Type
6.3 APAC Cardiothoracic Minimally Invasive Surgical Instruments Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cardiothoracic Minimally Invasive Surgical Instruments by Country
7.1.1 Europe Cardiothoracic Minimally Invasive Surgical Instruments Sales by Country (2017-2022)
7.1.2 Europe Cardiothoracic Minimally Invasive Surgical Instruments Revenue by Country (2017-2022)
7.2 Europe Cardiothoracic Minimally Invasive Surgical Instruments Sales by Type
7.3 Europe Cardiothoracic Minimally Invasive Surgical Instruments Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cardiothoracic Minimally Invasive Surgical Instruments by Country
8.1.1 Middle East & Africa Cardiothoracic Minimally Invasive Surgical Instruments Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cardiothoracic Minimally Invasive Surgical Instruments Revenue by Country (2017-2022)
8.2 Middle East & Africa Cardiothoracic Minimally Invasive Surgical Instruments Sales by Type
8.3 Middle East & Africa Cardiothoracic Minimally Invasive Surgical Instruments Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cardiothoracic Minimally Invasive Surgical Instruments
10.3 Manufacturing Process Analysis of Cardiothoracic Minimally Invasive Surgical Instruments
10.4 Industry Chain Structure of Cardiothoracic Minimally Invasive Surgical Instruments
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cardiothoracic Minimally Invasive Surgical Instruments Distributors
11.3 Cardiothoracic Minimally Invasive Surgical Instruments Customer
12 World Forecast Review for Cardiothoracic Minimally Invasive Surgical Instruments by Geographic Region
12.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Market Size Forecast by Region
12.1.1 Global Cardiothoracic Minimally Invasive Surgical Instruments Forecast by Region (2023-2028)
12.1.2 Global Cardiothoracic Minimally Invasive Surgical Instruments Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cardiothoracic Minimally Invasive Surgical Instruments Forecast by Type
12.7 Global Cardiothoracic Minimally Invasive Surgical Instruments Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.1.3 Medtronic Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Aesculap
13.2.1 Aesculap Company Information
13.2.2 Aesculap Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.2.3 Aesculap Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Aesculap Main Business Overview
13.2.5 Aesculap Latest Developments
13.3 Stryker Corporation
13.3.1 Stryker Corporation Company Information
13.3.2 Stryker Corporation Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.3.3 Stryker Corporation Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Stryker Corporation Main Business Overview
13.3.5 Stryker Corporation Latest Developments
13.4 Smith & Nephew
13.4.1 Smith & Nephew Company Information
13.4.2 Smith & Nephew Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.4.3 Smith & Nephew Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Smith & Nephew Main Business Overview
13.4.5 Smith & Nephew Latest Developments
13.5 Ethicon
13.5.1 Ethicon Company Information
13.5.2 Ethicon Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.5.3 Ethicon Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Ethicon Main Business Overview
13.5.5 Ethicon Latest Developments
13.6 Conmed Corporation
13.6.1 Conmed Corporation Company Information
13.6.2 Conmed Corporation Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.6.3 Conmed Corporation Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Conmed Corporation Main Business Overview
13.6.5 Conmed Corporation Latest Developments
13.7 Zimmer Holdings
13.7.1 Zimmer Holdings Company Information
13.7.2 Zimmer Holdings Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.7.3 Zimmer Holdings Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Zimmer Holdings Main Business Overview
13.7.5 Zimmer Holdings Latest Developments
13.8 MI
13.8.1 MI Company Information
13.8.2 MI Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.8.3 MI Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 MI Main Business Overview
13.8.5 MI Latest Developments
13.9 KARL STORZ
13.9.1 KARL STORZ Company Information
13.9.2 KARL STORZ Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.9.3 KARL STORZ Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 KARL STORZ Main Business Overview
13.9.5 KARL STORZ Latest Developments
13.10 Genesee BioMedical
13.10.1 Genesee BioMedical Company Information
13.10.2 Genesee BioMedical Cardiothoracic Minimally Invasive Surgical Instruments Product Offered
13.10.3 Genesee BioMedical Cardiothoracic Minimally Invasive Surgical Instruments Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Genesee BioMedical Main Business Overview
13.10.5 Genesee BioMedical Latest Developments
14 Research Findings and Conclusion